Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$128K Sell
1,600
-51,500
-97% -$3.88M ﹤0.01% 5684
2014
Q2
$3.77M Buy
53,100
+50,300
+1,796% +$3.54M ﹤0.01% 2220
2014
Q1
$207K Sell
2,800
-7,000
-71% -$528K ﹤0.01% 5156
2013
Q4
$769K Buy
9,800
+2,300
+31% +$180K ﹤0.01% 3832
2013
Q3
$554K Sell
7,500
-7,800
-51% -$575K ﹤0.01% 4024
2013
Q2
$1.16M Buy
+15,300
New +$1M ﹤0.01% 3161

Other funds holding CME

UBS's CME Position: Q3 2014 in Review

UBS increased its CME Group (CME) stake by 19% in Q3 2014, buying an estimated $14.4M and bringing the position to 1,219,548 shares worth $97.5M. The position accounts for 0.07% of the portfolio, ranked #272.

UBS first reported a position in CME in Q2 2013 and has held it in 6 quarters since. 543 funds tracked by Wall St. Rank hold CME as of Q3 2014.

  • UBS held 1,219,548 shares of CME Group worth $97.5M as of Q3 2014.
  • UBS bought 191,537 CME Group shares in Q3 2014, an estimated $14.4M.
  • CME Group made up 0.07% of UBS's portfolio in Q3 2014, its #272 holding.
  • UBS first reported a position in CME Group in Q2 2013 and has held it in 6 quarters since.
  • 543 funds tracked by Wall St. Rank held CME Group as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.